Simultaneous T(2) and T(2)* mapping of multiple sclerosis lesions with radial RARE-EPI by Herrmann, C. et al.
Magn Reson Med. 2021;00:1–20.    | 1wileyonlinelibrary.com/journal/mrm
Received: 10 December 2020 | Revised: 26 March 2021 | Accepted: 26 March 2021
DOI: 10.1002/mrm.28811  
F U L L  P A P E R
Simultaneous T2 and T∗2 mapping of multiple sclerosis lesions 
with radial RARE- EPI
Carl J. J. Herrmann1,2  |   Antje Els1 |   Laura Boehmert1  |   Joao Periquito1  |   
Thomas Wilhelm Eigentler1,3  |   Jason M. Millward1 |   Sonia Waiczies1  |   
Joseph Kuchling4,5,6 |   Friedemann Paul4,5,6 |   Thoralf Niendorf1,4
1Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
2Department of Physics, Humboldt University of Berlin, Berlin, Germany
3Chair of Medical Engineering, Technical University of Berlin, Berlin, Germany
4Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine, 
Berlin, Germany
5NeuroCure Clinical Research Center, Charité- Universitätsmedizin, Berlin, Germany
6Department of Neurology, Charité- Universitätsmedizin, Berlin, Germany
This is an open access article under the terms of the Creative Commons Attribution- NonCommercial License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited and is not used for commercial purposes.
© 2021 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine
Correspondence
Thoralf Niendorf, Berlin Ultrahigh Field 
Facility (B.U.F.F.), Max Delbrück Center 
for Molecular Medicine in the Helmholtz 




European Research Council (ERC) under 
the European Union’s Horizon 2020 
research and innovation program, Grant/
Award Number: 743077 (ThermalMR)
Purpose: The characteristic MRI features of multiple sclerosis (MS) lesions make 
it conceptually appealing to pursue parametric mapping techniques that support si-
multaneous generation of quantitative maps of 2 or more MR contrast mechanisms. 
We present a modular rapid acquisition with relaxation enhancement (RARE)- EPI 
hybrid that facilitates simultaneous T2 and T∗2 mapping (2in1- RARE- EPI).
Methods: In 2in1- RARE- EPI the first echoes in the echo train are acquired with a 
RARE module, later echoes are acquired with an EPI module. To define the frac-
tion of echoes covered by the RARE and EPI module, an error analysis of T2 and T∗2 
was conducted with Monte Carlo simulations. Radial k- space (under)sampling was 
implemented for acceleration (R = 2). The feasibility of 2in1- RARE- EPI for simulta-




laxation times of the brain. For validation, 2in1- RARE- EPI was benchmarked versus 
multi spin- echo (MSE) and multi gradient- echo (MGRE) techniques. The clinical ap-
plicability of 2in1- RARE- EPI was demonstrated in healthy subjects and MS patients.
Results: There was a good agreement between T2/T∗2 values derived from 2in1- 
RARE- EPI and T2/T∗2 reference values obtained from MSE and MGRE in both phan-
toms and healthy subjects. In patients, MS lesions in T2 and T∗2 maps deduced from 
2in1- RARE- EPI could be just as clearly delineated as in reference maps calculated 
from MSE/MGRE.
Conclusion: This work demonstrates the feasibility of radially (under)sampled 2in1- 
RARE- EPI for simultaneous T2 and T∗2 mapping in MS patients.
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1 |  INTRODUCTION
Multiple sclerosis (MS) is the most common chronic in-
flammatory demyelinating disease of the central nervous 
system.1,2 The pathological hallmark of MS is the accumu-
lation of demyelinating lesions in the grey and white matter 
of the brain.3,4 MRI is an indispensable tool for the diagnosis 
and monitoring of MS. It is used for tracking MS disease ac-
tivity, for prognostic evaluation, and for monitoring the ef-
ficacy and safety of disease- modifying treatments.5- 11 MRI 
findings have led to a better understanding of the underlying 
pathophysiology of the disease.12,13 Distinct lesion morphol-
ogy and anatomic distribution obtained from modern MRI 
techniques allows differentiation between MS and other 
neuroinflammatory diseases.13- 16 MRI protocols tailored for 
MS diagnosis and disease progression monitoring incorpo-
rate multiple MRI contrasts including T1, DWI, T2, FLAIR, 
and T∗
2
.17 Harmonization initiatives have provided consensus 
reports for MRI in MS, moving toward standardization and 
dissemination of protocols that facilitate clinical translation 
and comparison of data across sites.18- 22
T2- weighted imaging is well established and frequently 
used for identification of white matter (WM) lesions, which 
have a hyperintense appearance.5,23 Although being an im-
portant diagnostic criterion for MS,24 the WM lesion load 
correlates only weakly with clinical disability because of 
its lack of specificity for lesion severity and the underlying 
pathophysiology.5,23,25 This observation has triggered explo-
rations into parametric mapping of the transverse relaxation 
time T2. T2 prolongation was observed for normal appearing 
white matter26- 29 and could also be indicative of early MS.30 
T2 prolongations in diffusely abnormal white matter,
26 as 
well as deep gray matter,31 were reported as an enhanced cor-
relate for clinical disability, which is superior to the correla-
tion with the focal WM lesion load. For T2 mapping, multi 
spin- echo (MSE) techniques are most widely used. MSE 
techniques require long TRs to promote SNR and to miti-
gate T1 relaxation effects. This results in long scan times, in-
creases the propensity to bulk motion, and might induce slice 
misregistration in sequential protocols, which constrains the 
clinical applicability of T2 mapping. To overcome the scan 
time requirements, T2 mapping strategies that reduce TR
32- 
34 or take advantage of undersampling or acceleration strate-
gies35- 37 have been implemented.
T∗
2
- weighted imaging has become increasingly important 
in MS. The central vein sign5,13,16,38 and rim- like paramag-
netic phase changes39 in T∗
2
- weighted MRI are considered 
to be disease- specific imaging markers for MS lesions. T∗
2
 
is sensitive to iron deposition within lesion formations,40,41 
which may relate to disease duration, activity, and severity.42- 44 
Furthermore, T∗
2
 was reported to reflect brain tissue changes 
in patients with minor deficits and early MS, and therefore, 
may become a tool to assess the development of MS already at 
an early stage.30,45T∗
2
 mapping can differentiate new enhancing 
from non- enhancing MS lesions without gadolinium contrast 
agents, which helps avoid the risks of repeated administration 
of these agents.46- 48 Multi gradient- recalled echo (MGRE)- 
based techniques are commonly used for T∗
2
 mapping. These 
techniques use low flip angles for RF excitation that permit 
short TRs and facilitate clinically acceptable scan times.
Given the characteristic MRI features of MS lesions, it is 
conceptually appealing to pursue techniques that support si-
multaneous generation of quantitative maps of multiple MR 
contrasts.32,49- 60 Dual contrast techniques offer substantial 
scan time reduction, eliminate the risk for slice misregistra-
tion, improve the immunity to bulk motion, and boost clinical 
use. The current study presents a modular rapid acquisition 
with relaxation enhancement (RARE)- EPI hybrid, which is 
a combined acquisition technique variant.61 It facilitates si-
multaneous T2 and T∗2 mapping in a single radially (under)
sampled scan (2in1- RARE- EPI). To evaluate and define the 
fraction of echoes covered by the RARE module and the EPI 
module, an error analysis of T2 and T∗2 was conducted with 
Monte Carlo simulations. The feasibility of 2in1- RARE- EPI 
for simultaneous T2 and T∗2 mapping was examined in phan-
toms mimicking the T2 and T∗2 relaxation times of brain tissue. 
For validation of T2 and T∗2 mapping, 2in1- RARE- EPI was 
benchmarked against conventional MSE and MGRE tech-
niques. As a precursor to broader clinical studies, the clinical 
applicability of 2in1- RARE- EPI was demonstrated in an in 
vivo feasibility study with healthy subjects and MS patients.
2 |  METHODS
2.1 | RARE- EPI hybrid
The proposed 2in1- RARE- EPI is a combined acquisi-
tion technique variant based on a RARE- EPI hybrid62,63 In 
RARE- EPI, the first echoes in the echo train are acquired 
with a RARE module. Later echoes are acquired with an 
EPI module. The combined acquisition technique factor 
λ = NRARE ∗ NRARE + NEPI
−1 indicates the fraction of RARE 
echoes in the echo train, where NRARE and NEPI denote the 
number of echoes acquired in the RARE and EPI modules, 
respectively. We implemented a radial k- space data sampling 
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F I G U R E  1  (A) Pulse sequence diagram of the radially sampled 2in1- RARE- EPI hybrid. The acquisition of the MR signal with the RARE 
module (highlighted in light blue) is followed by an acquisition with the EPI module (highlighted in light orange). The first echo in the RARE 
module is discarded from the acquisition. The EPI module consists of a train of gradient- recalled echoes with bi- polar acquisition, where small 
blip gradients (marked in red) promote the transition from 1 spoke to the next. (B) Schematic k- space trajectory depicting the illustrative case that 
3 RARE and 4 EPI echoes (λ ≈ 0.43) are acquired in the respective modules using 8 shots. The view angles of all RARE echoes (solid lines) and 
all EPI echoes (dashed lines) are equally distributed. To mitigate motion artefacts in the TE images, the acquisition of k- space segments is equally 
distributed over the full π radians of k- space within cycles of 4 shots, as denoted by the grey numbers. Within each segment the RARE echoes 
and EPI echoes are acquired in sequential order, but in reversed directions, as denoted for example, for the second shot by the blue and orange 
numbers, respectively. The phantom (C) consisted of a 3D printed casing with integrated tube holders. (D) Schematic cross section of the phantom 
showing the tubes labelled with corresponding iron concentrations used in the phantom studies (iron concentration outside the tubes = 3.51 μg Fe/
mL). The ROIs (size: 9 × 9 pixels) used for further analysis of the phantom study are depicted in (E). Twelve ROIs are located within the tubes 
(blue squares), although 1 ROI is located within the body of the phantom (red square). The ROIs (size: 7 × 7 pixels) used for the scatter and BA 
plot analysis of the in vivo study involving healthy subjects were placed within the left and right globus pallidus and thalamus (F) and frontal white 
matter (G). (H) Exemplary signal decay derived from a central voxel of an ROI located in the left globus pallidus. Data were obtained with MSE 
and 2in1- RARE- EPI. The signal decay is normalized to 1 with respect to the second TE
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scheme to facilitate acceleration via k- space undersampling. 
The pulse sequence diagram and k- space trajectory are de-
picted in Figure 1A,B. To allow flexible view ordering of 
the RARE echoes, magnetization is completely rephased be-
fore the refocusing RF pulses. In the RARE module, the first 
spin echo is discarded from the data acquisition. The RARE 
module is followed by an EPI module, consisting of a train 
of gradient- recalled echoes with small blip gradients promot-
ing the transition from 1 spoke to the next. The view angles 
of all RARE and all EPI spokes are equally distributed over 
the whole π- radian in k- space. To reduce the propensity of 
the individual TE images to bulk motion, the acquisition of 
k- space segments is equally distributed over the whole π ra-
dians of k- space in cycles of 4 shots. This approach mitigates 
the grouping of motion- induced errors in k- space.64 Within 
k- space segments, the spokes were acquired sequentially, 
where the EPI spokes were collected in reversed order with 
respect to the RARE spokes. For T2 and T∗2 mapping, images 
reconstructed from the echoes acquired at the specific TEs 
were used.
2.2 | Monte Carlo simulations
Because the MR signal undergoes T2- decay in the RARE 
echo train, the SNR left for T∗
2
 mapping using the EPI echo 
train is governed by the duration of the RARE module and 
the T2 of the tissues under investigation. Therefore, it is 
reasonable to keep the duration of the RARE module short. 
Conversely, the sampling of the T2 decay over a broader time 
range is desirable to permit accurate estimation of long T2 
values. Similar considerations apply for the T∗
2
 decay within 
the EPI echo train. Based on these considerations, Monte 
Carlo simulations were performed to determine the number 
of echoes, NRARE and NEPI, which minimize the error in the 
T2 and T∗2 estimation. Synthetic data were generated using a 
mono- exponential decay as a simple model of the MR signal:
Here, M0 denotes the initial transverse magnetization, 
which was set to 1. The echo spacings used in the RARE 
and EPI module are denoted as ESPRARE and ESPEPI, whereas 
NRARE and NEPI denote the number of RARE and EPI echoes 
within the modules. The variable i represents the echo count 
of the echo train.
For white and gray matter, the literature reports the fol-
lowing T2 and T∗2 values obtained at 3.0 T: white matter: T2 
= 70- 90 ms30,65 and T∗
2
 = 50- 60 ms30,65; gray matter: T2 = 
100- 110 ms66,67 and T∗
2
 = 50- 70 ms.67,68 To cover this range, 
our simulations used T∗
2
 = 30- 70 ms (10 ms increments) and 
T2 = 70- 110 ms (20 ms increments).
In a loop of 30,000 repetitions, Rician noise was added to 
the synthetic data samples according to:
resulting in SNRs of 20 to 70. T2 and T∗2 were estimated for each 
repetition using a linear least- square- fit of ln(sε(i)). The error 
in T2 and T∗2 was determined by the mean absolute difference 
between the estimated and actual T2 and T∗2 values.
2.3 | MR study
All images were acquired at 3.0 T (Siemens Magnetom SkyraFit, 
Erlangen, Germany) using a 32- channel head RF coil (Siemens, 
Erlangen, Germany) for signal reception and the body RF coil 
for transmission. Before each scan session, volume- selective B0 
shimming of the brain was applied. All imaging data were cor-
rected for gradient delays69 using additional calibration data, 
which were acquired before each 2in1- RARE- EPI scan. In ac-
cordance with the method proposed by Block et al,69 calibration 
scans were performed for the phase encoding, and the read- out 
direction and an interpolation of the respective gradient delays 
was used for the correction of intermediate view angels. To 
make the correction more robust, the k- space shift was aver-
aged over 4 calibration scans. In total, this resulted in 16 shots 
for the whole calibration scan (TA = 32 s).
Images were reconstructed using regridding with linear 
density compensation70- 73 and a magnitude sum- of- squares 
channel combination. MSE and MGRE echo techniques 
(Siemens) were used as reference acquisition methods for T2 
and T∗
2
 mapping, respectively. The imaging parameters used 
for the phantom and in vivo studies are summarized in Table 1.
2.4 | T2 and T∗2  mapping
For T2 and T∗2, mapping images were reconstructed from k- 
space data acquired at the same TE (TE images). A linear 
least- square- fit of the logarithmic signal magnitude of the TE 
images was used to calculate the T2 and T∗2 maps. The last 
TE image of the RARE module was included as the first TE 
image for T∗
2
 mapping. To determine the goodness- of- fit of 
the linear regression, R2 maps (coefficient of determination) 
were calculated according to Equation (3), where yi and fi 
denote the logarithmic signal intensity and the corresponding 
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Because of stimulated echoes, there is a signal change between 
the first and second echo, as can be seen in the signal decay de-
picted in Figure 1H. To account for this, we used a dummy echo 
in the 2in1- RARE- EPI. This might still lead to misestimations 
of T2, especially for short T2 values. For the compensation of 
stimulated echoes, a fitting method based on extended phase 
graphs can be used, which incorporates the first echo of the T2 
decay.74
2.5 | Phantom study
To examine the feasibility of simultaneous T2 and T∗2 
mapping with 2in1- RARE- EPI, a phantom study was per-
formed. An in- house constructed phantom (Figure 1C- G) 
was used to mimic the T2 and T∗2  of brain tissue. The phan-
tom consisted of an array of 12 plastic tubes (volume = 
15 mL, diameter = 15 mm) filled with water doped with 
varying concentrations of the iron oxide nanoparticle- 
based contrast agent Resovist (Schering, Berlin, Germany), 
which modifies T2 and T∗2  of the solvent.
75- 78 The iron con-
centrations of the different solutions ranged between 2.3 
to 12.3  μg  Fe/mL (Figure 1F). Based on the relaxivity 
r∗
2
 = 5.2 ± 0.1 mL μg−1 s−1 of the contrast agent reported 
in a previous study78 and an R∗
2,water
 = 1.35 s−1, calculated 
from data provided in Dahnke and Schaeffter78, this yields 
T∗
2
 values in the range of 15 ms to 83 ms According to 
the relaxivity r2 = 2.56 ± 0.2 mL μg
−1 s−1 of the contrast 
agent76 and an R2,water = 0.32 ± 0.06 s
−1,76 this results in T2 
values ranging between 31 ms and 161 ms.
2.6 | Ethics statement
For the in vivo feasibility study, approval by the local ethical 
committee (Charité- Universitätsmedizin, Berlin, Germany, 
EA1/191/19) was obtained before the study. Informed writ-
ten consent was obtained from each volunteer before the 
study.
2.7 | In vivo study
To demonstrate the feasibility of simultaneous T2 and T∗2 
mapping with 2in1- RARE- EPI, in vivo examinations were 
performed on healthy volunteers (n = 3, sex: female [1]/
male [2], age: 31- 46 years, body mass index [BMI]: 23.6- 
25.9 kg/m2) and MS patients (n = 4, sex: female [3]/male 
[1], age: 30- 39 years, BMI: 22.3- 34.9 kg/m2). For the 
healthy volunteers, 3 brain slices covering the lateral ven-
tricles were acquired. This brain area was chosen because it 
contains prominent anatomic features and because MS le-



























































































































































































































































































































































































































































































































































































6 |   HERRMANN Et Al.
In the patient cohort, MS- specific lesions were selected to 
be imaged with the 2in1- RARE- EPI, based on a transversal 
2D T2- weighted RARE scan. The lesions were identified 
from 2D T2- weighted RARE images. The anatomic posi-
tions of the MS lesions are illustrated on sagittal and trans-
versal views of images from a T2- weighted 3D SPACE 
pulse sequence (Siemens) acquisition (TR = 2050 ms, TE 
= 712 ms, 1 mm isotropic resolution). For multi- slice MR 
acquisitions, an interleaved acquisition scheme was used 
for 2in1- RARE- EPI and MSE, and a sequential slice acqui-
sition was used for MGRE.
2.8 | Scatter and Bland- Altman plot analysis
Agreement between T2 and T∗2 maps obtained with the 2in1- 
RARE- EPI method and the reference methods was evalu-
ated using scatter plot and Bland- Altman (BA) plot analysis 
on values from selected regions of interest (ROIs). For the 
phantom study, 6 ROIs (size: 9 × 9 pixels) with varying iron 
concentration were placed within different tubes and 1 ROI 
within the main body of the phantom as outlined in Figure 
1E by blue and red squares, respectively. For the analysis of 
the data obtained from healthy subjects, 6 ROIs (size: 7 × 7 
pixels) were placed bilaterally in 3 brain regions: the globus 
pallidus, thalamus, and frontal (perivascular) white matter of 
the brain (Figure 1F,G). For the patient cohort, 8 ROIs (size: 
7 × 7 pixels) covering selected MS lesions in 4 patients were 
used for the analyses. Before the scatter and BA plot analysis, 
T2 and T∗2 maps obtained with 2in1- RARE- EPI and the refer-
ence methods were co- registered to correct for translational 
displacement because of bulk head motion. For this purpose, 
difference maps between the T2 and T∗2 reference maps and 
the T2 and T∗2 maps obtained with 2in1- RARE- EPI were cal-
culated for 8 translational shifts of the reference maps by 
1 pixel relative to the maps obtained with 2in1- RARE- EPI 
including diagonal shifts. The shift that provided clearly re-
duced values in the difference maps at sharp anatomic bound-
aries, determined by visual inspection, was applied to the 
reference maps before the scatter and BA analysis. Multiple 
linear regression was used to assess the agreement between 
the methods while also accounting for the effects of ROI and 
subject, and their interaction. In some cases, the differences 
of T2 and T∗2 values among the respective methods did not 
follow a Gaussian distribution, and therefore the median 
of the T2 and T∗2 differences, M(∆T2) and M(∆T
∗
2
) and the 
interquartile range (iQR) were used to calculate the limits- 
of- agreement (LOAs) shown on the BA plots according to 
Equation (4)
3 |  RESULTS
3.1 | Monte Carlo simulations
Monte Carlo simulations were performed to determine the 
number of echoes, NRARE and NEPI, for which the errors in the 
T2 and T∗2 estimation are minimized. The map in Figure 2A 
shows the maximum error in T2 AND T∗2 estimations for all 
T2 and T∗2 combinations and SNRs used in the simulations 
as a function of the number of RARE and EPI echoes. The 
plot shows that the maximum absolute error is substantially 
decreased for NRARE = 13- 15 and for NEPI = 18- 20. Based 
on this finding, an echo train length of 32 echoes was used 
for 2in1- RARE- EPI imaging of phantoms and human sub-
jects comprising 14 RARE echoes followed by 18 EPI ech-
oes. For this configuration of RARE and EPI echoes the plot 
of the absolute error in T2 and T∗2 over SNR is depicted in 
Figure 2B. These data show that the estimated absolute error 
in T2 and T∗2 is lower than 2 ms for SNRs larger than 20. In 
comparison to the maximum absolute error, the maximum 
relative error in T2 and T∗2 is minimized for a slightly lower 
number of RARE and EPI echoes (Figure 2C,D). For the im-
aging study, NRARE = 14 and NEPI = 18 was used because we 
considered the minimization of the absolute error to be of 
higher priority in cases where small variations of the relaxa-
tion time constants are relevant. The SNR estimates for the 
2in1- RARE- EPI in the phantom study yielded an SNR within 
the 13 ROIs ranging from 160 to 260. The SNR estimates 
for the 2in1- RARE- EPI in a healthy subject yielded an SNR 
between 90 and 120 for the ROIs within the thalamus and 
globus pallidus and between 180 and 210 for ROIs within 
the frontal white matter. This is well beyond the SNR range 
used in the simulations. This shows that the SNR drop in the 
EPI module because of the T2 decay is not consequential. In 
cases of very short T2 values, the length of the RARE and EPI 
module can be adapted. Further simulations including a T2 
value of 50 ms yielded relative errors of ~5% for a T∗
2
 of 20 
ms. In this case, the ideal number of echoes changes to NRARE 
= 8 and NEPI = 13.
3.2 | Phantom study
T2, T∗2, and R
2 maps obtained from the phantom study are 
depicted in Figure 3 together with selected TE images. The 
depicted TE images highlight that the image quality is not 
impaired by the radial undersampling. The parametric maps 
demonstrate the decrease in T2 and T∗2 with increasing iron 
concentration. The tubes containing identical iron concentra-
tion (Figure 1G) revealed similar T2 and T∗2 values. The T2 






± 1.45 ⋅ iQR.
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reference T2 map deduced from MSE (Figure 3, top panel). 
The corresponding R2 maps show values close to 1, indicat-
ing a low fraction of unexplained variance in the logarithmic 
signal intensity, based on the T2 values obtained with linear 
regression. The T∗
2
 maps obtained with the proposed 2in1- 
RARE- EPI approach accord well with those deduced from 
the MGRE reference (Figure 3, bottom panel). The corre-
sponding R2 maps exhibit lower R2 values compared to those 
obtained for the T2 mapping.
Quantitative comparisons of the T2 and T∗2  values de-
rived from 2in1- RARE- EPI acquisitions versus those ob-
tained with reference methods (MSE and MGRE), and 
2in1- RARE- EPI with NRARE = 1 versus MGRE are shown 
in Figure 4. For this comparison, 13 ROIs (size: 9 × 9 pix-
els) were placed in the phantom as shown in Figure 1G. 




values within the ROIs as a function of the iron concentra-
tions. As a comparison R2 and R∗2  values, calculated from 
relaxivities provided by previous studies,76,78 are depicted 
as black lines. For R2, the measured values deviate from 
the calculated values. The mean R2 values obtained with 
2in1- RARE- EPI match those obtained with MSE, espe-
cially for the lower iron concentrations. For both methods, 
the relaxivity agrees well with the values provided in the 
literature.76 For R∗
2
, the measured values are in agreement 
with the calculated reference R∗
2
 values.
The results of the scatter and BA plot analysis are shown 
in Figure 4B,C. For T2, the multiple regression analy-
sis shows a strong relationship between 2in1- RARE- EPI 
and MSE (accounting for the different iron concentrations 
F I G U R E  2  Results of Monte Carlo simulations of T2 and T ∗2  estimation errors. (A) Maximum absolute error in T2 and T
∗
2
 for a varying 
number of echoes used in the RARE and EPI module (NRARE and NEPI) and SNRs ranging between 20 and 70. The maximum absolute error in T2 
and T ∗
2
 is minimized for NRARE = 14 and NEPI = 18. (B) The absolute error in T2 (left) and T ∗2  (right), for NRARE = 14 and NEPI = 18 and different 
combinations of T2 and T ∗2  values, as a function of SNR. (C) Maximum relative error in T2 and T
∗
2
 for varying NRARE and NEPI and SNRs ranging 




(right), for NRARE = 11 and NEPI = 16 and different combinations of T2 and T ∗2 , as a function of SNR
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within the ROIs): F[13,553] = 9427, adjusted R2 = 0.995, 
P < 2.2 × 10−16. The BA plot analysis yielded a median 
difference of M(∆T2) = 1.6 ms between the T2 values, 
and LOAs of 4. 6 and −1.4 ms. The scatter plot used for 
benchmarking T∗
2
 obtained from 2in1- RARE- EPI against 
MGRE also shows a good agreement between the methods, 
F[13,553] = 2497, adjusted R2 = 0.983, P < 2.2 × 10−16, 
which is confirmed by the BA plot with M(∆T∗
2
) = −4. 8 ms 
and LOAs of 1.5 ms and −11.0 ms The comparison between 
the 2in1- RARE- EPI with NRARE = 1 and MGRE yielded 
similar results, F[13,553] = 2815, adjusted R2 = 0.985, P < 
2.2 × 10−16, although the BA plot showed a broader range 
of differences, with M(∆T∗
2
) = 3.7 ms, and LOAs of 15.8 
ms and −8.5. Overall, these results demonstrate the good 
correspondence between the T2 and T∗2  relaxation times ob-
tained simultaneously with 2in1- RARE- EPI and those de-
rived from sequential MSE and MGRE acquisitions
3.3 | In vivo study
Next, the applicability of 2in1- RARE- EPI was demonstrated 
in an in vivo feasibility study involving healthy subjects. 
Figure 5 shows T2 and T∗2 maps with the corresponding R
2 
maps, and a selection of individual TE images of the brain 
of an exemplary healthy subject. The depicted TE images 
highlight that the image quality is not impaired by the radial 
undersampling. The T2 maps obtained with 2in1- RARE- EPI 
F I G U R E  3  T2, T ∗2 , and R
2 maps (coefficient of determination) and selected TE images of an in- house built phantom containing plastic tubes 
filled with varying concentrations of iron oxide nanoparticles. The iron concentrations of the solutions in the tubes and the body of the phantom 
are listed in Figure 1. The intensity of each TE image is normalized with respect to the minimum and maximum intensity. A good agreement was 
observed between the T2 map obtained with 2in1- RARE- EPI and the reference T2 map obtained with MSE, and between the T ∗2  map derived from 
2in1- RARE- EPI and the reference T ∗
2
 map deduced from MGRE. The selected TE images highlight that the image quality is not impaired by the 
radial undersampling
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agreed with the maps from MSE. The corresponding R2 maps 
obtained for 2in1- RARE- EPI and MSE exhibit high values, 
indicating a low fraction of unexplained variance in the 
logarithmic signal intensity for both methods. The T∗
2
 map 
obtained with 2in1- RARE- EPI accords with the T∗
2
 map de-
duced from MGRE. For both approaches, the R2 values are 
lower than the corresponding R2 values found for T2 estima-
tions. Note that the TE images acquired with the EPI module 
of 2in1- RARE- EPI feature a mixed T2 and T∗2 weighting. The 
TE images obtained with the 2in1- RARE- EPI with NRARE = 
1 show a similar T∗
2
 weighting as the TE images obtained 
with the MGRE. Consistent with the phantom study, the R2 
values of the T∗
2
 map of the 2in1- RARE- EPI (NRARE = 1) are 
slightly higher compared to the corresponding values for the 
2in1- RARE- EPI (NRARE = 14).
Quantitative comparisons of T2 and T∗2 values between 
2in1- RARE- EPI and the reference methods are shown in 
Figure 6 including data from all 3 healthy subjects. T2 and 
T∗
2
 values were calculated in 6 ROIs (size: 7 × 7 pixels), 
which were placed within regions where MS lesions typically 
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emerge: globus pallidus, thalamus, and frontal (perivascular) 
white matter (Figure 1H). Multiple regression analysis of the 
T2 values shows a strong relationship between the proposed 
2in1- RARE- EPI and the reference method MSE, accounting 
for effects of the different anatomic regions and different 
subjects, and their interactions: F[17,864] = 118.6, adjusted 
R2 = 0.6942, P = 3.75 × 10−212. The regression analysis for 
the T∗
2
 comparison between 2in1- RARE- EPI and MGRE re-
vealed a strong relationship: F[17,864] = 46.48, adjusted R2 
= 0.4674, P = 2.50 × 10−309. The T∗
2
 comparison between 
2in1- RARE- EPI (NRARE = 1) and MGRE yielded similar re-
sults: F[17,864] = 40.59, adjusted R2 = 0.4331, P = 7.46 
× 10−98 (Figure 6A).These results were supported by the 
BA plots: 2in1- RARE- EPI versus MSE: M(∆T2) = 0.3 ms 
with LOAs of 6.5 ms and −5.8 ms; 2in1- RARE- EPI versus 
MGRE: M(∆T∗
2
) = 3.1 with LOAs of 18.5 ms and −12.3 ms; 
2in1- RARE- EPI (NRARE = 1) and MGRE M(∆T∗2) = −2.1 
ms, LOAs of 10.4 ms and −14.6 ms (Figure 6B).
Following the feasibility study in healthy subjects, 2in1- 
RARE- EPI was applied in MS patients. Figure 7 depicts T2 
and T∗
2
 maps of the brain of a 30- year- old female MS patient. 
The parametric maps show 3 periventricular MS lesions ad-
jacent to the right lateral ventricle. The first 2 columns of 
Figure 7 highlight an MS lesion adjacent to the posterior 
horn of the right lateral ventricle. The lesion clearly appears 
hyperintense in the T2 map. The T2 map obtained with 2in1- 
RARE- EPI is in good accordance with the T2 map derived 
from MSE. The white matter lesion is also clearly delineated 
in the T∗
2
 maps calculated from 2in1- RARE- EPI and MGRE 
data. The third and fourth columns of Figure 7 highlight 2 le-
sions adjacent to the anterior and posterior horns of the right 
lateral ventricle. Both lesions are clearly delineated in the T2 
and T∗
2
 maps obtained with 2in1- RARE- EPI and with the ref-
erence methods MSE and MGRE.
T2 and T∗2 maps obtained from a 54- year- old male MS pa-
tient are shown in Figure 8. Sagittal and transversal anatomic 
views in the first row of Figure 8 show 2 lesions, targeted for 
T2 and T∗2 mapping with 2in1- RARE- EPI and the reference 
methods (MSE and MGRE). The first 2 columns of Figure 
8 show T2 and T∗2 maps highlighting a periventricular lesion 
adjacent to the right lateral ventricle. The lesion is clearly de-
lineated in the T2 and T∗2 maps. The third and fourth columns 
show T2 and T∗2 maps highlighting a juxtacortical lesion 
located in the left posterior hemisphere. This lesion is also 
clearly delineated in the T2 and T∗2 maps. The maps derived 
from 2in1- RARE- EPI are consistent with those from MSE 
and MGRE imaging.
Quantitative comparisons of the T2 and T∗2 values ob-
tained from the MS patients using the 2in1- RARE- EPI ver-
sus the reference methods are shown in Figure 9. T2 and T∗2 
values were obtained from ROIs corresponding to the lo-
cation of the lesions shown in the representative images in 
Figures 7 and 8 (size: 7 × 7 pixels). Data from 2 additional 
patients is included in the quantitative analysis, for a total of 
8 ROIs corresponding to separate lesions. Multiple regres-
sion analysis of the T2 values shows a strong relationship 
between the proposed 2in1- RARE- EPI and the reference 
method MSE, accounting for effects of the different pa-
tients, and their separate lesions (a separate regression line 
is shown for each lesion): F[8,383] = 577.2, adjusted R2 = 
0.9218, P = 2.01 × 10−208. The regression analysis for the T∗
2
 
comparison between 2in1- RARE- EPI and MGRE revealed a 
strong relationship: F[8,383] = 137, adjusted R2 = 0.7356, 
P = 2.12 × 10−107. These results were supported by the BA 
plots: 2in1- RARE- EPI versus MSE: M(∆T2) = −0.3 ms and 
LOAs of 10.3 ms and −10.9 ms; 2in1- RARE- EPI versus 
MGRE: M(∆T∗
2
) = 8.6 ms with LOAs of 25.1 ms and −7.5 
ms; (Figure 9B).
4 |  DISCUSSION
This work demonstrates the feasibility of radially sampled 
2in1- RARE- EPI for simultaneous T2 and T∗2  mapping. Our 
F I G U R E  4  Quantitative comparisons of the T2 and T ∗2  values obtained from the phantom studies presented in Figure 3. (A) Mean relaxation 
rates R2 = 1/T2 and R ∗2  = 1/T
∗
2
 (taken from 13 ROIs, size: 9 × 9 pixel, placed within the phantom, see Figure 1), as a function of the iron 
concentration of the solutions corresponding to the ROIs. Error bars indicate the SD of the values within the ROIs. For comparison the calculated 
R2 and R ∗2  values, based on the relaxivities of the contrast agent and the intercepts reported by previous studies (r2 = 2.6 ± 0.2 mL μg
−1 s−1, R2,water 
= 0.32 ± 0.06 s−1, and r ∗
2
 = 5.2 ± 0.1 mL/μg−1 s−1, R ∗
2,water
 = 0.09 s−1)76,78 are depicted as solid black lines. The margin of error is indicated by a 
grey shade. R ∗
2,water
 was calculated from data provided in Dahnke and Schaeffter.78 R2,water and r2 were measured at 37°C,
76 whereas our phantom 
study was conducted at room temperature. (B) Scatter plots comparing T2 and T ∗2  values derived from 2in1- RARE- EPI acquisitions versus those 
obtained with reference methods (MSE and MGRE) and 2in1- RARE- EPI with NRARE = 1 versus MGRE. Color of the data points is scaled with 
iron concentration, indicated at the bottom of the figure. Multiple linear regression shows a strong relationship between the values obtained with 
2in1- RARE- EPI and the reference methods, while accounting for the effect of different iron concentration: 2in1- RARE- EPI versus MSE: F[13,553] 
= 9427, adjusted R2 = 0.995, P < 2.2 × 10−16 2in1- RARE- EPI versus MGRE: F[13,553] = 2497, adjusted R2 = 0.983, P < 2.2 × 10−16; 2in1- 
RARE- EPI with NRARE = 1 versus MGRE: F[13,553] = 2815, adjusted R
2 = 0.985, P < 2.2 × 10−16. (C) BA plots corresponding to the scatter 
plots shown in (B). The following values for the median of the T2 and T ∗2  differences (solid black line) and the upper and lower limits- of- agreement 
(LOAs = M(ΔT( ∗ )
2
) ± 1.45 × iQR, dashed black line) were obtained from the BA plot analysis: 2in1- RARE- EPI versus MSE: M(ΔT2) = 1.6 ms, 
LOAs = 4. 6 ms and −1.4 ms; 2in1- RARE- EPI versus MGRE: M(ΔT ∗
2
) = −4. 8 ms, LOAs = 1.5 ms and −11.0 ms and 2in1- RARE- EPI with 
NRARE = 1 versus MGRE: M(ΔT ∗2) = 3.7 ms, LOAs = 15.8 ms and −8.5 ms
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evaluation study in a phantom, equipped with solutions 
of different iron concentrations mimicking the T2 and T∗2 
relaxation properties of brain tissue, showed good agree-
ment between the T2 and T∗2  values obtained with 2in1- 
RARE- EPI and the reference parametric maps calculated 
from MSE and MGRE acquisitions. At low iron concentra-
tions, there was a tendency for 2in1- RARE- EPI to slightly 
underestimate the T2, compared to MSE, whereas T∗2  was 
rather overestimated compared to MGRE at low iron con-
centrations, but only for 2in1- RARE- EPI with NRARE = 1. 
For the T∗
2
 values obtained with MGRE, a larger spread 
was observed compared to the T∗
2
 values obtained with 
2in1- RARE- EPI, which leads to a slight trend in the BA 
plots, depending on the ROI. This observation is mainly 
F I G U R E  5  T2 and T ∗2  maps along with the R
2 maps (coefficient of determination) and selected TE images of the brain of a healthy female 
subject. The intensity of each TE image is normalized with respect to the minimum and maximum intensity within the brain tissue. The 2 rows 
at the top show the image data derived from the reference method MSE and those derived from 2in1- RARE- EPI. Good agreement between both 
T2 maps was observed. Both R
2 maps exhibit R2 values close to 1 throughout the brain. The 3 rows at the bottom show the image data derived 
from the reference method MGRE and those derived from 2in1- RARE- EPI and 2in1- RARE- EPI with NRARE = 1. Good agreement was observed 
between the T ∗
2
 maps derived by the different methods. The R2 values observed in the 3 R2 maps, although lower than those derived from the T2 
mapping with MSE and 2in1- RARE- EPI, are in a reasonable range. The selected TE images highlight that the image quality is not impaired by the 
radial undersampling
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because of a lower SNR in the MGRE images, which var-
ies with the iron concentration because of the change in 
T1. The observed deviation of the measured R2 values 
from the values calculated based on literature76 can be re-
lated to the fact that the relaxivity of the contrast agent 
and R2,water were measured at 37°C,
76 whereas our phantom 
study was conducted at room temperature. For the solu-
tion with the highest iron concentration an overestimation 
of T∗
2
 obtained with 2in1- RARE- EPI was observed. This 
could be because of the rather long EPI module compared 
to the short T∗
2
 values, leading to an increased noise level in 
later TE images, which is already increased because of the 
preceding T2 decay. This finding has no adverse effect on 
the application of the 2in1- RARE- EPI for characterizing 
pathophysiological changes in brain tissue during MS, be-
cause such low T2 and T∗2  values are mainly not featured by 
the relevant tissues in the brain at 3.0 T.
The agreement of T2 and T∗2 values obtained with the 
2in1- RARE- EPI with the values obtained from reference 
methods was corroborated in the feasibility study conducted 
in healthy subjects. The patient study also demonstrated that 
MS lesions can be just as clearly distinguished in the T2 and 
T∗
2
 maps obtained from 2in1- RARE- EPI acquisitions, when 
compared to reference maps derived from conventional T2 
and T∗
2
 mapping using MSE/MGRE techniques.
In the current feasibility study, the evaluation of simul-
taneous T2 and T∗2 mapping with 2in1- RARE- EPI was re-
stricted to MS lesions and tissues with intermediate to long 
F I G U R E  6  Results of the scatter and BA plot analysis of the T2 and T ∗2  values calculated from the brain scans of the 3 healthy subjects 
(denoted by square, circle, and triangle). Data points are colored according to the anatomical location of the ROIs (size: 7 × 7 pixels) as depicted in 
Figure 1F,G: thalamus, blue; globus pallidus, red; frontal white matter, green; left and right hemisphere = dark, light. (A) Scatter plots comparing 
T2 and T ∗2  derived from 2in1- RARE- EPI acquisitions versus those obtained with reference methods (MSE and MGRE), and 2in1- RARE- EPI 
with NRARE = 1 versus MGRE. Multiple linear regression shows a strong relationship between the values obtained with 2in1- RARE- EPI and the 
reference methods, while accounting for the effect of different anatomical region and subject, and their interactions (separate regression lines for 
each anatomical region are depicted): 2in1- RARE- EPI versus MSE: F[17,864] = 118.6, adjusted R2 = 0.6942, P = 3.75 × 10−212; 2in1- RARE- EPI 
versus MGRE: F[17,864] = 46.48, adjusted R2 = 0.4674, P = 2.50 × 10−309; 2in1- RARE- EPI with NRARE = 1 versus MGRE: F[17,864] = 40.59, 
adjusted R2 = 0.4331, P = 7.46 × 10−98. (B) BA plots corresponding to the scatter plots shown in (A). The following values for the median of the 
T2 and T ∗2  differences (solid black line) and limits- of- agreement (LOAs = M(ΔT
( ∗ )
2
) ± 1.45 × iQR,dashed black line) were obtained from the BA 
plot analysis: 2in1- RARE- EPI versus MSE: M(ΔT2) = 0.3 ms, LOAs = 6.5 ms and −5.8 ms; 2in1- RARE- EPI versus MGRE: M(ΔT ∗2) = 3.1 ms, 
LOAs = 18.5 ms and −12.3 ms; 2in1- RARE- EPI with NRARE = 1 versus MGRE: M(ΔT ∗2) = −2.1 ms, LOAs = 10.4 ms and −14.6 ms
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T2 values. Further studies are needed to evaluate the per-
formance of the method for tissues exhibiting low T2 val-
ues (e.g., as a result of increased iron deposition), which is 
a pathological feature of some neurodegenerative diseases, 
including MS. In such cases, the length of the RARE and 
EPI modules can be adapted accordingly to achieve optimal 
results. Our proof- of- principle study used mono- exponential 
fitting for T2 mapping. This approach yields a weighted aver-
age of tissue T2, which might not be sufficiently specific for 
all brain pathologies. More pathology- specific information 
could be obtained using multi- exponential fitting to differen-
tiate multiple relaxation components or tissue compartments. 
This approach would benefit the quantification of micro-
structural tissue changes, demyelination processes, and my-
elin water content,79,80 which may predict MS conversion.81
A caveat of our feasibility study is that it used a limited 
number of slices (n = 3) rather than whole brain coverage. To 
better adapt this approach to clinical requirements, the slice 
thickness (5 mm) could be reduced, which would decrease 
partial volume effects and yield a better coverage of lesions. 
Reducing the slice thickness would be feasible regarding the 
high SNR estimated for the 2in1- RARE- EPI with the param-
eters of the current study. The acquisition of more slices can 
be easily achieved without increasing the acquisition time be-
cause of the long TR used in 2in1- RARE- EPI.
The simultaneous acquisition of T2 and T∗2 maps with 2in1- 
RARE- EPI entails a trade- off between a long RARE module 
to decrease estimation errors for long T2 values and a rather 
short RARE module to preserve SNR for the acquisition with 
the subsequent EPI module. Moreover, a short overall echo 
F I G U R E  7  T2 and T ∗2  maps of the brain of an MS patient (female, age: 30 years) obtained with 2in1- RARE- EPI and with reference methods 
MSE and MGRE. The position of the lesions targeted for T2 and T ∗2  mapping are presented in sagittal and transversal views acquired with a T2- 
weighted 3D SPACE pulse sequence (top row). The cyan line in the sagittal view indicates the position of the transverse slice. The first 2 columns 
depict a periventricular MS lesion located adjacent to the posterior horn of the right lateral ventricle (highlighted by white arrow). The third and 
fourth columns present T2 and T ∗2  maps of 2 periventricular MS lesions adjacent to the right lateral ventricle. All 3 MS lesions are clearly delineated 
in the T2 and T ∗2  maps. The maps acquired with 2in1- RARE- EPI are consistent with those obtained with MSE and MGRE
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train length is desirable for optimal slice coverage efficiency 
in multi- slice acquisitions. Taking these considerations into 
account, our Monte Carlo simulations identified the appro-
priate numbers of RARE and EPI echoes for the respective 
modules needed to minimize the relative and absolute error 
in T2 and T∗2. These results were then incorporated into the 
phantom and the in vivo studies of healthy volunteers and 
MS patients.
MRI examinations targeting MS typically involve a series 
of multiple imaging contrasts and MR- metrics, resulting in 
long examination times and a greater propensity to motion 
artifacts and slice mis- registration.18- 20 Dual or multi- contrast 
techniques offer the potential for substantial scan time reduc-
tion. The undersampled 2in1- RARE- EPI hybrid approach 
used in the current study permits reduced acquisition time 
for T2 and T∗2 mapping compared to conventional sequential 
mapping methods. The EPI module in 2in1- RARE- EPI only 
slightly increases the echo train length within the long TR 
needed to account for T1 effects. Unlike 2in1- RARE- EPI, 
MGRE uses a short TR promoted by a low flip angle. The 
short TR dictates that multiple slices are commonly acquired 
sequentially, which leads to a linear increase in the acquisi-
tion time with the number of slices. Consequently, increasing 
the number of slices to achieve whole- brain coverage em-
phasizes the scan time savings of 2in1- RARE- EPI compared 
to sequential T2 and T∗2 mapping using MSE and MGRE. 
Further acceleration is promoted by radial undersampling 
of k- space. In this way, the acquisition time for T2 and T∗2 
maps of 3 slices was reduced to 76% using 2- fold undersam-
pled 2in1- RARE- EPI. Assuming an imaging volume with 25 
F I G U R E  8  T2 and T ∗2  maps of the brain of an MS patient (male, age: 54 years) obtained with 2in1- RARE- EPI and with the reference methods 
MSE and MGRE. The position of the lesions targeted for T2 and T ∗2  mapping are presented in sagittal and transversal views acquired with a 
T2- weighted 3D SPACE (top row). The cyan line in the sagittal view indicates the position of the transverse slice. The first 2 columns show a 




 maps depicting a juxtacortical MS lesion in the left anterior hemisphere. Both lesions are clearly delineated in the T2 and T ∗2  maps. The maps 
acquired with 2in1- RARE- EPI are consistent with those obtained with MSE and MGRE
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slices, the acquisition time could be reduced to 62% com-
pared to the sequential acquisition with MSE/MGRE using 
Cartesian sampling.
Further acquisition time shortening can be enabled by 
multiband RF pulses for simultaneous multi- slice imaging. 
An unfortunate corollary of the RARE module is the number 
of refocusing pulses required, which might deteriorate the 
specific absorption rate economy of 2in1- RARE for simul-
taneous multi- slice imaging. Slice accelerated acquisition 
schemes using power- independent number of slices RF 
pulses is a promising approach to offset RF power deposition 
while improving imaging speed and spatial coverage.82- 84 
The 2in1- RARE- EPI approach is compatible with the con-
cept of hyperechoes85 and variable refocusing flip angles86 
that can serve to further offset specific absorption rate for 
multiband applications.
Our study demonstrates that 2in1- RARE- EPI permits si-
multaneous T2 and T∗2 mapping within clinically acceptable 
F I G U R E  9  Results of the scatter plots (A) and BA plot (B) analysis of T2 and T ∗2  values obtained for the lesions from MS patients depicted 
in Figure 7 (circles) and 8 (squares), and lesions from 2 additional MS patients (triangles, diamonds). The analysis benchmarks 2in1- RARE- EPI 
against the sequential acquisition using the MSE and MGRE reference methods. Data points are colored according to the ROIs (size: 7 × 7 pixels) 
covering each separate lesion (8 lesions total). (A) Scatter plots comparing T2 and T ∗2  derived from 2in1- RARE- EPI acquisitions versus those 
obtained with reference methods (MSE and MGRE). Multiple linear regression shows a strong relationship between the values obtained with 2in1- 
RARE- EPI and the reference methods, while accounting for the effect of different patient and different lesions (separate regression lines for each 
individual lesion are depicted): 2in1- RARE- EPI versus MSE: F[8,383] = 577.2, adjusted R2 = 0.9218, P = 2.01 × 10−208; 2in1- RARE- EPI versus 
MGRE: F[8, 383] = 137, adjusted R2 = 0.7356, P = 2.12 × 10−107 (B) BA plots corresponding to the scatter plots shown in (A). The following 
values for the median of the T2 and T ∗2  differences (solid black line) and limits- of- agreement (LOAs = M(ΔT
( ∗ )
2
) ± 1.45 × iQR , dashed black line) 
were obtained from the BA plot analysis: 2in1- RARE- EPI versus MSE: M(ΔT2) = −0.3 ms , LOAs = 10.3 ms and −10.9 ms; 2in1- RARE- EPI 
versus MGRE: M(ΔT ∗
2
) = 8.6 ms, LOAs = 25.1 ms and −7.5 ms; (C) ROIs covering the lesions of patients 1 and 2
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scan times. Streamlining acquisition times is crucial for in-
corporating these important MR metrics into broader clinical 
studies, and ultimately into routine practice. Therefore, 2in1- 
RARE- EPI may provide a valuable contribution for enhancing 
and developing future MRI- based diagnostics and monitoring 
of MS and related disorders. Potential improvements may 
cover various aspects ranging from emerging MR techniques 
to track MS disease activity,5,8,9,23,87 including detection of 
transient enlargement of the ventricles during relapsing- 
remitting MS88 and volumetric and microstructural measure-
ments,89- 92 to the enhancement of our understanding of the 
underlying fundamental pathophysiology of the disease.12 
For example, the assessment of changes in T2 could provide a 
more robust correlate for clinical disability than the T2 lesion 
count.26,31 It has also been suggested that a prolongation of T2 
in NAWM could be an indicator for early MS.30 Because of its 
sensitivity to iron deposition and its dependency on tissue my-
elination level, T∗
2
 mapping could provide insights into disease 
activity.42- 44 Furthermore, T∗
2
 mapping might become a tool to 
assess MS already at an early stage of the disease.30,45 2in1- 
RARE- EPI also promises to support the differential diagnosis 
of MS and other neurodegenerative diseases, including or-
phan diseases.14,15 This is beneficial in a clinical context, but 
also in preclinical studies involving experimental MS models 
in small rodents and nonhuman primates where multiple MR 
metrics are assessed.93- 95 Moreover, simultaneous acquisition 
of multiple contrasts obviates the need for slice co- registration 
when combining multiple series of images. 2in1- RARE- EPI 
may also provide an endogenous contrast- based alternative for 
the assessment of the incidence of enhancing lesions or the le-
sion acuity in longitudinal MRI exams of MS patients, which 
commonly use exogenous intravenous gadolinium- based con-
trast agents for routine follow- up imaging.96- 98
The T2 and T∗2 maps derived from 2in1- RARE- EPI offer 
the capacity for the calculation of R′
2
 maps, which is concep-
tually appealing for probing the spatial distribution of mag-
netic susceptibility effects.99,100 This could be beneficial for 
the assessment of chronic active MS lesions that are char-
acterized by a rim of iron- enriched activated microglia and 
macrophages, probing iron levels in the deep gray matter, and 
for identifying regions of demyelination and iron accumula-
tion during the formation of MS lesions.101
The potential of the proposed 2in1- RARE- EPI hybrid 
is not limited to MS lesions or even brain imaging. 2in1- 
RARE- EPI offers the capacity for simultaneous T2 and T∗2 
mapping in applications dealing with bulk or physiological 
motion, such as cardiac imaging including myocardial T2 and 
T∗
2
 mapping,102- 104 as well as multi- parametric MRI of the 
eye, kidney, abdomen, and liver.105- 110 For these applications 
in moving organs, motion correction approaches such as 1D 
or 2D linear phase correction promise to ensure immunity 
to bulk motion.111,112 The use of radial k- space trajectories 
shown in the current study holds the promise to render ad-
ditional navigator data unnecessary because the densely 
sampled k- space center can be deployed for phase correc-
tion of motion corrupted data. This approach promotes self- 
calibrated motion compensation techniques.
5 |  CONCLUSION
To conclude, the proposed 2in1- RARE- EPI hybrid consti-
tutes a tool to advance quantitative mapping of T2 and T∗2 
particularly during brain pathology. The reduced scan time 
promotes patient comfort and is a fundamental precursor to 
boosting the implementation of quantitative mapping in clini-
cal routine practice, and to conducting broader clinical stud-
ies on the potential of T2 and T∗2 as biomarkers in MS. This 
work demonstrates the feasibility of 2in1- RARE- EPI for T2 
and T∗
2
 of MS patients, although the range of applications 
can be extended to several other brain pathologies as well as 
other target anatomy, disorders, and diseases. Recognizing 
the spin- physics of 2in1- RARE- EPI, this strategy can also 
be adapted to support simultaneous T2, T∗2 and temperature 
mapping.
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